GSK Total Assets 2010-2022 | GSK

GSK total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • GSK total assets for the quarter ending September 30, 2022 were $71.037B, a 34.53% decline year-over-year.
  • GSK total assets for 2021 were $108.775B, a 5.33% increase from 2020.
  • GSK total assets for 2020 were $103.273B, a 1.49% increase from 2019.
  • GSK total assets for 2019 were $101.759B, a 31.29% increase from 2018.
GSK Annual Total Assets
(Millions of US $)
2021 $108,775
2020 $103,273
2019 $101,759
2018 $77,507
2017 $72,664
2016 $80,072
2015 $81,719
2014 $66,997
2013 $65,856
2012 $65,742
2011 $65,909
2010 $65,025
2009 $67,118
GSK Quarterly Total Assets
(Millions of US $)
2022-09-30 $71,037
2022-06-30 $111,796
2022-03-31 $120,345
2021-12-31 $108,775
2021-09-30 $108,504
2021-06-30 $107,646
2021-03-31 $107,671
2020-12-31 $103,273
2020-09-30 $104,542
2020-06-30 $105,030
2020-03-31 $108,093
2019-12-31 $101,759
2019-09-30 $102,649
2019-06-30 $81,812
2019-03-31 $81,230
2018-12-31 $77,507
2018-09-30 $76,361
2018-06-30 $78,441
2018-03-31 $78,151
2017-12-31 $72,664
2017-09-30 $76,959
2017-06-30 $74,468
2017-03-31 $73,374
2016-09-30 $77,205
2016-06-30 $82,689
2016-03-31 $78,058
2015-12-31 $81,719
2015-09-30 $82,363
2015-06-30 $82,887
2015-03-31 $87,928
2014-12-31 $66,997
2014-09-30 $67,346
2014-06-30 $65,385
2014-03-31 $65,723
2013-12-31 $65,856
2013-09-30 $63,721
2013-06-30 $64,611
2013-03-31 $66,641
2012-12-31 $65,742
2012-09-30 $63,912
2012-06-30 $67,235
2012-03-31 $64,100
2011-12-31 $65,909
2011-09-30 $66,753
2011-06-30 $68,671
2011-03-31 $68,167
2010-12-31 $65,025
2010-09-30 $66,096
2010-06-30 $64,231
2010-03-31 $69,571
2009-12-31 $67,118
2009-09-30 $68,039
2009-06-30 $55,675
2009-03-31 $56,322
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $71.890B $46.910B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $172.495B 10.52
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.433B 19.52
Ginkgo Bioworks Holdings (DNA) United States $3.861B 0.00
Myovant Sciences (MYOV) United Kingdom $2.605B 0.00
Arcus Biosciences (RCUS) United States $2.586B 38.81
Biohaven (BHVN) United States $1.141B 0.00
Emergent Biosolutions (EBS) United States $0.599B 4.71
Zymeworks (ZYME) Canada $0.478B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.278B 0.00
Enzo Biochem (ENZ) United States $0.096B 0.00
SQZ Biotechnologies (SQZ) United States $0.046B 0.00
Gelesis Holdings (GLS) United States $0.035B 0.00
Ambrx Biopharma (AMAM) United States $0.019B 0.00